Clinical Trial Update: The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% [Phase 1, Phase 2]

View source ↗

Summary

A pharmacokinetic study comparing topical levofloxacin 1.5% with topical moxifloxacin 0.5% in endophthalmitis, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis

Drugs mentioned

• Topical levofloxacin 1.5% (levofloxacin)
• Topical moxifloxacin 0.5% (moxifloxacin)

Snippet

Sponsor: National University of Malaysia | Conditions: Endophthalmitis | Phase 1, Phase 2 | Status: UNKNOWN